Table 4.
Appropriateness of imipenem-cilastatin, meropenem and piperacillin-tazobactam prescriptions.
| Antimicrobial | Type of indication | Appropriate | Inappropriate |
|---|---|---|---|
| Imipenem-cilastatin | Empiric (n = 466) |
63.5% | 36.5% |
| Targeted (n = 294) |
87% | 13% | |
| Prophylaxis (n = 6) |
0% | 100% | |
| Meropenem | Empiric (n = 691) |
57.9% | 42.1% |
| Targeted (n = 291) |
79.4% | 20.6% | |
| Prophylaxis (n = 21) |
0% | 100% | |
| Piperacillin-tazobactam | Empiric (n = 2874) |
52.3% | 47.7% |
| Targeted (n = 171) |
57.9% | 42.1% | |
| Prophylaxis (n = 115) |
0.9% | 99.1% |